SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasionPetra Mlčochová, Uma Sharma, Steven A. Kemp et al.|Nature|2021Cited by 1.4k
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicityBo Meng, Jenny Kourampa, Adam Abdullahi et al.|Nature|2022Cited by 1.2k
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2Dami A. Collier, Josh Hodgson, Isabella A.T.M. Ferreira et al.|Nature|2021Cited by 816
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023Masayuki Teramoto, Hassan Abolhassani, Samar Abd ElHafeez et al.|The Lancet|2025Cited by 386
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023Emily Haeuser, Bilyaminu Abubakar, Sam Byrne et al.|The Lancet|2025Cited by 93